FDA 510(k)

EnCor EnCompass™ Breast Biopsy and Tissue Removal System

N.º K: K252681 · 2025-12-12

SolicitanteBard Peripheral Vascular, Inc.

Fecha de decisión2025-12-12

Código de productoKNW

Comité asesorGU

DecisiónSubstantially Equivalent

Resumen del dispositivo

EnCor EnCompass™ Breast Biopsy and Tissue Removal System is the device name listed in this FDA 510(k) record. The listed applicant is Bard Peripheral Vascular, Inc.. It received FDA 510(k) clearance on 2025-12-12 under 510(k) number K252681. The device is classified under product code KNW. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the EnCor EnCompass™ Breast Biopsy and Tissue Removal System?

EnCor EnCompass™ Breast Biopsy and Tissue Removal System is a medical device that received FDA 510(k) clearance on 2025-12-12. The listed applicant is Bard Peripheral Vascular, Inc.. The 510(k) number is K252681.

When did EnCor EnCompass™ Breast Biopsy and Tissue Removal System receive FDA 510(k) clearance?

EnCor EnCompass™ Breast Biopsy and Tissue Removal System received FDA 510(k) clearance on 2025-12-12, under 510(k) number K252681.

Who is the listed applicant for EnCor EnCompass™ Breast Biopsy and Tissue Removal System?

The FDA 510(k) record lists Bard Peripheral Vascular, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EnCor EnCompass™ Breast Biopsy and Tissue Removal System?

The FDA product code for EnCor EnCompass™ Breast Biopsy and Tissue Removal System is KNW.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Bard Peripheral Vascular, Inc. como solicitante

K262571EnCor EnCompass™ Breast Biopsy and Tissue Removal System K260012UltraScore™ Focused Force PTA Balloon K250032Marquee™ Disposable Core Biopsy Instrument and Instrument Kit K250219Dorado™ PTA Balloon Dilatation Catheter K243642UltraCor™ Twirl™ Breast Tissue Marker K242757Rotarex Atherectomy System

Ver todos los 18 dispositivos →

Dispositivos relacionados (Código: KNW)

K260517Automatic Core Biopsy InstrumentZhejiang Curaway Medical Technology Co., Ltd.K262571EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemBard Peripheral Vascular, Inc.K262792Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09)Hologic, Inc.K260572Marrow MarxmanMedimetrix, LLC K261196Promisemed VeriEcto Automatic Biopsy NeedlesPromisemed Hangzhou Meditech Co., Ltd.K260365Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Control Module; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Disposable Probe, 8 gauge; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Disposable Targeting Set, 8 gauge; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Foot Switch; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Reusable Tray; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Battery CharDevicor Medical Products, Inc.

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.